NANOCOMPOSIX, INC.
SAN DIEGO, CA, 92111
Prime contracting experience
4 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN AND SYNTHESIS A NEW PLGA BASED NANOPARTICLE WITH NANOPARTICLE WITH OPTIMAL PROTEIN-ADJUVANT FORMULATION COMBINING BOTH TARGETING AND CONTROLLED DELIVERY FOR IMMUNIZATION AGAINST HIV. | — | $299,040 | Jul 8, 2025 | Jun 1, 2020 – Nov 30, 2022 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | LATERAL FLOW ASSAY DEVICES | — | $300,000 | Jan 26, 2024 | Sep 28, 2022 – Sep 25, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | THE OBJECTIVE IS TO DEVELOP CMV IGG AND IGM LATERAL FLOW ASSAYS REQUIRED TO SUPPORT A LARGE SCALE CMV VACCINATION TRIAL. | — | $1,500,000 | Apr 11, 2023 | Jul 31, 2019 – Jul 31, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | THE OBJECTIVE OF THIS CONTRACT IS TO GENERATE AN EFFECTIVE HIV VACCINE USING THE TARGETED AND CONTROLLED DELIVERY OF ANTIGENS TO ANTIGEN PRESENTING CELLS (APC). ENGINEERED NANOPARTICLES LOADED WITH MRNA CAPTURED BEHIND PH SENSITIVE POLYMER, TARGETED WITH MANNOSE WILL BE EMPLOYED TO INDUCE A HIV-SPECIFIC AND CELLULAR IMMUNE RESPONSE. | — | $600,000 | Apr 1, 2022 | Jun 17, 2019 – Sep 16, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
2 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | PERIOD 1: MATERIAL, SUPPLIES, AND LABOR FOR NANOCOMPOSIX TO COMPLETE TRANSFER AVANTGEN'S PROTOTYPE COVID-19 RAPID ANTIGEN TEST TO MANUFACTURING. 15907 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 334516 Parent award performance state: CA Parent award description: RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #7360 - HIGHLY SENSITIVE RAPID TEST KIT FOR SARS-COV-2 THAT DOES NOT REQUIRE A READER View parent award on USAspending | — | $217,213 | Dec 20, 2021 | — – — |
| Subcontractor | Department of Health and Human Services | MATERIAL, SUPPLIES, AND LABOR FOR NANOCOMPOSIX TO PRODUCT THE PILOT LOT-1 FOR CLINICAL TRIAL. 15907 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 334516 Parent award performance state: CA Parent award description: RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #7360 - HIGHLY SENSITIVE RAPID TEST KIT FOR SARS-COV-2 THAT DOES NOT REQUIRE A READER View parent award on USAspending | — | $240,078 | Dec 17, 2021 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.